Paediatric Meningioangiomatosis PD-L1+: A Case Report
DOI:
https://doi.org/10.20344/amp.22276Keywords:
Angiomatosis, Child, Immune Checkpoint Inhibitors, MeningiomaAbstract
N/A
Downloads
References
Roux A, Zanello M, Mancusi RL, Still ME, Nascimento FA, Tauziede-Espariat A, et al. Meningioangiomatosis: multimodal analysis and insights from a systematic review. Neurology. 2021;96:274-86. DOI: https://doi.org/10.1212/WNL.0000000000011372
Whiting DM, Awad IA, Miles J, Chou SS, Lüders H. Intractable complex partial seizures associated with occult temporal lobe encephalocele and meningoangiomatosis: a case report. Surg Neurol. 1990;34:318-22. DOI: https://doi.org/10.1016/0090-3019(90)90007-C
Tauziède-Espariat A, Masliah-Planchon J, Sievers P, Sahm F, Dangouloff-Ros V, Boddaert N, et al. A comprehensive histomolecular characterization of meningioangiomatosis: further evidence for a precursor neoplastic lesion. Brain Pathol. 2024;34:e13259. DOI: https://doi.org/10.1111/bpa.13259
Gaggero G, Campora M, Taietti D, Cerruti G, Lo Bue E, Truffelli M, et al. Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression. Autops Case Rep. 2022;12:e2021394. DOI: https://doi.org/10.4322/acr.2021.394
Wang Y, Zhang C, Yan M, Ma X, Song L, Wang B, et al. PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas. CNS Neurosci Ther. 2024;30:e14784. DOI: https://doi.org/10.1111/cns.14784
Chen K, Huang Z, Liu C, Ouyang Q, Yan Q, Zheng W, et al. Hsa_ circ_0004872 mitigates proliferation, metastasis and immune escape of meningioma cells by suppressing PD-L1. Metab Brain Dis. 2024;39:895-907. DOI: https://doi.org/10.1007/s11011-024-01345-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

